PUBLISHER: TechNavio | PRODUCT CODE: 1581799
PUBLISHER: TechNavio | PRODUCT CODE: 1581799
Stem Cell Umbilical Cord Blood (UCB) Market 2024-2028
The stem cell umbilical cord blood (UCB) market is forecasted to grow by USD 1688.5 mn during 2023-2028, accelerating at a CAGR of 18.5% during the forecast period. The report on the stem cell umbilical cord blood (UCB) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of several chronic disorders, increased federal investment in stem cell therapy, and advent of cord blood banking.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 15.2% |
CAGR | 18.5% |
Incremental Value | $1688.5 mn |
Technavio's stem cell umbilical cord blood (UCB) market is segmented as below:
By End-user
By Geographical Landscape
This study identifies the increasing investments in field of regenerative medicines as one of the prime reasons driving the stem cell umbilical cord blood (UCB) market growth during the next few years. Also, increasing awareness, associated research, and potential clinical applications for stem cell and rising emergence of personalized medicine will lead to sizable demand in the market.
The report on the stem cell umbilical cord blood (UCB) market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell umbilical cord blood (UCB) market vendors that include Americord Registry LLC, Athersys Inc., CBR Systems Inc., Cells4Life Group LLP, Celularity Inc., Cordlife Group Ltd., CRYO-CELL International Inc, Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FamiCord Group, FUTURE CELL JAPAN, Global Cord Blood Corp., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., Next Biosciences Pty Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Smith and Nephew plc, ViaCord LLC, and Vita 34 AG. Also, the stem cell umbilical cord blood (UCB) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: